Gateway Bio is a biotech startup that aims to address antibiotic resistance with a new type of drug delivery system. They are developing a modular nanocarrier platform that delivers antibiotics directly into bacterial cells, bypassing bacterial defense mechanisms. The platform is widely applicable to different types of antibiotics and works against both gram-positive and gram-negative bacteria.

Startup highlights

Other startups & participants

AromAB
AromAb is developing a new technology to purify antibodies for biological drugs more quickly and che...
Aziflu
Aziflu is developing new antiviral drugs against influenza (flu). Their focus is on treatments that ...
CaraOmics
CaraOmics is developing a platform for building “clinical digital twins”: digital models of patients...
Omivera
Omivera is developing a platform called CellEKT that allows pharmaceutical researchers to better mea...
QDiaMon
QDiaMon is a healthtech startup developing a wearable device that can measure multiple biomarkers fr...
HeartSmart
HeartSmart is a biotech startup developing a human heart tissue model to improve heart failure drug ...
Radigene
Radigene develops a novel imaging technology that makes therapeutic cells visible inside the body. B...
ONEIRA
Oneira is a biotech startup working to improve cancer treatments by being able to better direct ther...
Vindi Biosystems
Vindi Biosystems is developing a wearable device for continuous, real-time monitoring of disease ass...
SBMatrices
SBMatrices is making a synthetic, animal-free gel with Fybrix in which you can grow cells for resear...
GlycoDiagnostics
GlycoDiagnostics aims to detect people with potentially dangerous liver disease early on, before it ...
GameAnalyze
GameAnalyze is building a wellbeing solution that helps parents discover behavioral patterns of the ...